Deerfield Private Design Fund IV, L.P.

10% owner at Larimar Therapeutics, Inc. · on record since Feb 16, 2024
* Director by Deputization at Larimar Therapeutics, Inc. · on record since Feb 16, 2024
10% owner at AdaptHealth Corp. · on record since Mar 12, 2024
*Possible Member of 10% Group at AdaptHealth Corp. · on record since Mar 12, 2024
10% owner at Nuvalent, Inc. · on record since Oct 24, 2024
10% owner at SPYR, Inc. · on record since Nov 13, 2024
Director by Deputization at Nuvalent, Inc. · on record since Oct 24, 2024
Director at Nuvalent, Inc. · on record since Jul 28, 2021
Director at AdaptHealth Corp. · on record since Feb 23, 2018
Director at Starling Oncology, Inc. · on record since Mar 17, 2020
Director at Larimar Therapeutics, Inc. · on record since Jun 8, 2020
Director at SPYR, Inc. · on record since Nov 10, 2022

Insider trading activity of Deerfield Private Design Fund IV, L.P.

Transactions on record: 25; since Nov 13, 2019

Open-market buys: 1; $10M

Open-market sells: 12; $6.3M

Companies traded: 4; last filing Mar 12, 2024

Figures computed from official regulatory filings — .

Companies where Deerfield Private Design Fund IV, L.P. has traded

AdaptHealth Corp.9 tx · $127.8M · Mar 12, 2024
Mirum Pharmaceuticals, Inc.7 tx · $2.5M · Jun 8, 2022
Edgewise Therapeutics, Inc.7 tx · $10M · Mar 30, 2021
Starling Oncology, Inc.2 tx · $50M · Mar 17, 2020

Track record of Deerfield Private Design Fund IV, L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Deerfield Private Design Fund IV, L.P.

Co-insiders of Deerfield Private Design Fund IV, L.P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
AdaptHealth Corp.Listing on record	Mar 12, 2024	Sell	-47,992	10.92 USD	$524.1K	SEC
AdaptHealth Corp.Listing on record	Mar 12, 2024	Sell	-94,567	10.92 USD	$1M	SEC
AdaptHealth Corp.Listing on record	Mar 12, 2024	Sell	-114,906	10.70 USD	$1.2M	SEC
AdaptHealth Corp.Listing on record	Mar 12, 2024	Sell	-88,040	11.13 USD	$979.9K	SEC
AdaptHealth Corp.Listing on record	Mar 12, 2024	Sell	-4,495	11.03 USD	$49.6K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 8, 2022	Sell	-171	25.08 USD	$4.3K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 8, 2022	Sell	-155	25.08 USD	$3.9K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 8, 2022	Sell	-11,868	25.29 USD	$300.1K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 8, 2022	Sell	-13,132	25.29 USD	$332.1K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 8, 2022	Sell	-6,909	24.47 USD	$169.1K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 8, 2022	Sell	-6,243	24.47 USD	$152.8K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jul 13, 2021	Sell	-99,325	15.81 USD	$1.6M	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	OtherD (derivative)	-433,551	—	—	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	OtherD (derivative)	-1,301,626	—	—	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	Other	433,551	—	—	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	Other	1,301,626	—	—	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	Buy	625,000	16.00 USD	$10M	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	Other	1,572,960	—	—	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	OtherD (derivative)	-1,572,960	—	—	SEC
Starling Oncology, Inc.Security delisted	Mar 17, 2020	Other	2,500,000	10.00 USD	$25M	SEC
Starling Oncology, Inc.Security delisted	Mar 17, 2020	Other	2,500,000	10.00 USD	$25M	SEC
AdaptHealth Corp.Listing on record	Nov 13, 2019	Other	-652,253	0.00 USD	—	SEC
AdaptHealth Corp.Listing on record	Nov 13, 2019	Award	12,400,000	10.00 USD	$124M	SEC
AdaptHealth Corp.Listing on record	Nov 13, 2019	OtherD (derivative)	-460,685	0.00 USD	—	SEC
AdaptHealth Corp.Listing on record	Nov 13, 2019	Other	-6,087	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
AdaptHealth Corp.Listing on record	Mar 12, 2024	Sell	-47,992	10.92 USD	$524.1K	SEC
AdaptHealth Corp.Listing on record	Mar 12, 2024	Sell	-94,567	10.92 USD	$1M	SEC
AdaptHealth Corp.Listing on record	Mar 12, 2024	Sell	-114,906	10.70 USD	$1.2M	SEC
AdaptHealth Corp.Listing on record	Mar 12, 2024	Sell	-88,040	11.13 USD	$979.9K	SEC
AdaptHealth Corp.Listing on record	Mar 12, 2024	Sell	-4,495	11.03 USD	$49.6K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 8, 2022	Sell	-171	25.08 USD	$4.3K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 8, 2022	Sell	-155	25.08 USD	$3.9K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 8, 2022	Sell	-11,868	25.29 USD	$300.1K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 8, 2022	Sell	-13,132	25.29 USD	$332.1K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 8, 2022	Sell	-6,909	24.47 USD	$169.1K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 8, 2022	Sell	-6,243	24.47 USD	$152.8K	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jul 13, 2021	Sell	-99,325	15.81 USD	$1.6M	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	OtherD (derivative)	-433,551	—	—	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	OtherD (derivative)	-1,301,626	—	—	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	Other	433,551	—	—	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	Other	1,301,626	—	—	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	Buy	625,000	16.00 USD	$10M	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	Other	1,572,960	—	—	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	OtherD (derivative)	-1,572,960	—	—	SEC
Starling Oncology, Inc.Security delisted	Mar 17, 2020	Other	2,500,000	10.00 USD	$25M	SEC
Starling Oncology, Inc.Security delisted	Mar 17, 2020	Other	2,500,000	10.00 USD	$25M	SEC
AdaptHealth Corp.Listing on record	Nov 13, 2019	Other	-652,253	0.00 USD	—	SEC
AdaptHealth Corp.Listing on record	Nov 13, 2019	Award	12,400,000	10.00 USD	$124M	SEC
AdaptHealth Corp.Listing on record	Nov 13, 2019	OtherD (derivative)	-460,685	0.00 USD	—	SEC
AdaptHealth Corp.Listing on record	Nov 13, 2019	Other	-6,087	0.00 USD	—	SEC